title: Scleroderma mimics.
abstract: Scleroderma is a rare systemic autoimmune disease with multiple organ manifestations, including skin fibrosis. The groups of disorders classified as scleroderma mimics share the common thread of skin thickening but are otherwise quite incongruous in terms of underlying disease process and other organ involvement. This article reviews the clinical presentation, etiology, and treatment options available for scleroderma mimics, including morphea, scleredema, diabetic cheiroarthropathy, scleromyxedema, nephrogenic systemic fibrosis, and eosinophilic fasciitis. Through greater understanding of these diseases and the associated extradermal implications, we hope to facilitate recognition of scleroderma and its mimics.
authors: BIDMC, Division of Rheumatology and Lupus Center, Harvard University School of Medicine, Boston, MA 02215, USA. jnashel@bidmc.harvard.edu
authors: Jennifer
authors: J
authors: Nashel
authors: Virginia
authors: V
authors: Steen
mesh_terms: D003937:Diagnosis, Differential; D004802:Eosinophilia / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D005208:Fasciitis / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D006801:Humans; D054989:Nephrogenic Fibrosing Dermopathy / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D012592:Scleredema Adultorum / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D012594:Scleroderma, Localized / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D053718:Scleromyxedema / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy